ATU (France — nominative) in India
How the atu (france — nominative) pathway operates in India.
About ATU (France — nominative)
France's Authorization for Temporary Use, nominative form.
How ATU (France — nominative) works in India
India's CDSCO permits import of unapproved drugs under Rule 36 for personal use by patients with a prescription from a registered medical practitioner. Named Patient import is common for rare-disease indications.
Patients in India seeking access under ATU (France — nominative) typically follow this flow: a licensed physician in India issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in India
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 1 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.